Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

Rhea-AI Summary

Artivion (NYSE: AORT) has scheduled the release of its fourth quarter and full year 2024 financial results for Monday, February 24, 2025, after market close. The company will host a teleconference call and live webcast at 4:30 p.m. ET on the same day, featuring Chairman, President and CEO Pat Mackin, followed by a Q&A session.

Participants can join the live teleconference by dialing 201-689-8261. A replay will be available approximately one hour after the event by calling 877-660-8653 (toll-free) or 201-612-7415, using conference number 13749878. Both the live webcast and replay will be accessible through the Investors section of Artivion's website.

ATLANTA, Feb. 10, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2024 financial results will be released on Monday, February 24, 2025 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13749878. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion Lance A. Berry Executive Vice President & Chief Financial Officer Phone: 770-419-3355	Gilmartin Group LLC Brian Johnston / Laine Morgan Phone: 332-895-3222 investors@artivion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-fourth-quarter-and-full-year-2024-financial-results-302372746.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) release Q4 and full year 2024 earnings?

Artivion will release its Q4 and full year 2024 financial results on Monday, February 24, 2025, after market close.

What time is Artivion's (AORT) Q4 2024 earnings call?

Artivion's Q4 2024 earnings call is scheduled for 4:30 p.m. ET on Monday, February 24, 2025.

How can investors access Artivion's (AORT) Q4 2024 earnings call?

Investors can access the live call by dialing 201-689-8261, or through the webcast on Artivion's website in the Investors section at www.artivion.com.

How can investors access the replay of Artivion's (AORT) Q4 2024 earnings call?

The replay will be available by calling 877-660-6853 (toll-free) or 201-612-7415, using conference number 13749878, or through Artivion's website.